AIM AIM ImmunoTech Inc.
$0.18
AIM ImmunoTech Inc. (AIM) Earnings News
Earnings press releases, previews and reviews for AIM ImmunoTech Inc. (AIM), newest first.
Monday
August 10, 2026
8:36 AM ET
AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer
Monday
April 13, 2026
6:00 PM ET
AIM ImmunoTech Provides Routine Update on Annual Filings